![]() Adocia Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. | ![]() Eagle Pharmaceuticals Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas. | AiCuris AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents. | |
Founding Date | Founding Date 2005 | Founding Date 2007 | Founding Date 2006 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Lyon-3E-Arrondissement, FR HQ | Locations Woodcliff Lake, US HQ Chicago, US | Locations Wuppertal, DE HQ Borken, DE |
Employees | Employees 75 | Employees 10813% increase | Employees 731% increase |
Valuation ($) | Valuation ($) 158 m | Valuation ($) 5.2 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €9.3m (FY, 2024) | Revenue (est.) $316.6m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods €1.1m (FY, 2024) | Cost of goods $85.5m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit €11m (FY, 2024) | Gross profit $231.2m (FY, 2022) | Gross profit N/A |
Net income | Net income (€9.3m) (FY, 2024) | Net income $35.6m (FY, 2022) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 37m | Total funding raised $ 12.3m | Total funding raised $ 74.8m |

Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.
View companyAiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents.
View company